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In many human cancers, p27 downregulation correlates with a worse prognosis, suggesting that p27 levels
could represent an important determinant in cell transformation and cancer development. Using a mouse
model system based on v-src-induced transformation, we show here that p27 absence is always linked to a more
aggressive phenotype. When cultured in three-dimensional contexts, v-src-transformed p27-null fibroblasts
undergo a morphological switch from an elongated to a rounded cell shape, accompanied by amoeboid-like
morphology and motility. Importantly, the acquisition of the amoeboid motility is associated with a greater
ability to move and colonize distant sites in vivo. The reintroduction of different p27 mutants in v-src-
transformed p27-null cells demonstrates that the control of cell proliferation and motility represents two
distinct functions of p27, both necessary for it to fully act as a tumor suppressor. Thus, we highlight here a new
p27 function in driving cell plasticity that is associated with its C-terminal portion and does not depend on the
control of cyclin-dependent kinase activity.
Dissemination of tumor cells is strictly linked to their ability
to attach to and move within the extracellular matrix (ECM) in
a three-dimensional (3D) environment. The use of 3D exper-
imental model systems revealed that a higher complexity in cell
migration and adaptation responses exists in the 3D model
than in the classical 2D model (10, 16, 41, 49). A striking
example is given by the fact that only in 3D could individually
migrating cells use different mechanisms such as mesenchymal
and amoeboid motility (16, 17). The relative slow mesenchymal
migration is characterized by a fibroblast-like spindle shape
and is dependent on integrin-mediated adhesion and on pro-
tease function (16). The amoeboid motility can in some cases
represent a less adhesive, integrin-independent type of move-
ment. Cells use a propulsive mechanism and are highly de-
formable, and rather than degrade the matrix, they are able to
squeeze through it (16). As a result, the cells that use the
amoeboid motility can potentially move faster than cells that
use a mesenchymal strategy. Mesenchymal and amoeboid
movements are also characterized by a different involvement of
small GTPases of the Rho family. A high RhoA activity is
associated mainly with the amoeboid motility, while the mes-
enchymal migration needs a high Rac activity at the leading
edge to promote the extension of cellular protrusions (41, 48).
Under certain circumstances, cancer cells can undergo conver-
sion from a mesenchymal toward an amoeboid motility, an
event referred as mesenchymal-amoeboid transition (MAT)
(50). MAT represents a putative escape mechanism in tumor
cell dissemination that could be induced by inhibition of peri-
cellular proteolysis (50) or by increased membrane-associated
RhoA activity (18, 40).
Key mediators of cell motility through ECM substrates are
the members of the Src family kinases. The prototype of Src
family kinases, c-Src (14), is activated following cell-ECM ad-
hesion and contributes to regulate the focal adhesion turnover
and the cytoskeletal modifications necessary for normal cell
adhesion and motility (52). The c-Src gene is the proto-onco-
gene of the transforming gene v-src of Rous sarcoma virus, and
its elevated protein level and activity have been found in many
human tumors (20, 28, 27, 34). Despite the accumulation of
information and new molecular understanding of how Src is
controlled, there is still an incomplete picture about its role in
the generation of the malignant phenotype. v-Src shows higher
levels of the kinase activity and transforming ability than c-Src
(14, 15, 52). It induces normal cells to acquire a variety of
transformed features, including alteration of morphology and
increase of invasion ability due to its role in focal adhesion
remodeling (7, 9, 13).
Many data suggest that there is a close relationship between
cell-ECM interaction and the proliferation and movements in
both normal and tumor cells (5, 38, 43). Accordingly, Src ac-
tivation may influence not only cell motility but also cell cycle
progression by targeting the cell cycle inhibitor p27kip1 to pro-
teasomal degradation (22, 39). Recent evidences indicated that
p27kip1 (hereafter called p27) can also regulate cell migration,
even though its role still remains controversial since it has been
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reported to either block or stimulate cell movements (1, 4, 11,
19, 21, 23, 29, 45).
Based on these notions, we tested the possible contribution
of p27 to the growth and motility phenotypes induced by v-src
transformation, with special regard to those cellular invasive
features that can be observed in 3D environments. By studying
in vitro and in vivo the behavior of wild-type (WT) and p27-
null fibroblasts transformed with v-src, we highlight a new role
for p27 in the regulation of cellular plasticity that can ulti-
mately drive tumor cell shape, motility, and invasion.
MATERIALS AND METHODS
Cell cultures and development of stable cell lines. 3T3-p27WT and p27-knock-
out (p27KO) fibroblasts were described previously (1). All cell lines were grown
in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) (Sigma). To obtain stable cell clones, pM-vSrc (generously
provided by Renato Baserga, Thomas Jefferson University, Philadelphia, PA)
was cotransfected with pTRE2pur (Clontech) or pMSCV-Hyg (Clontech) vector.
All of the p27-rescued clones were obtained using retroviral transduction as
reported previously (1). Briefly, retroviral transduction was performed by tran-
siently transfecting the pMSCV vectors coding for p27T187A and p271-170 into
EcoPack 293 cells (Clontech). Three days later, conditioned medium from three
100-mm dishes containing the retroviruses was used to transduce one 100-mm
dish of exponentially growing p27WT or p27KO fibroblasts. Clones and mass
transfections were selected and maintained in complete medium with puromycin
(1.5 g/ml) and/or hygromycin (0.4 mg/ml).
Preparation of cell lysates, immunoblotting, and immunoprecipitation. Cell
lysates were prepared using cold NP-40 lysis buffer (0.5% NP-40, 50 mM HEPES
[pH 7], 250 mM NaCl, 5 mM EDTA, 0.5 mM EGTA [pH 8]) plus a protease
inhibitor cocktail (Complete; Roche), 1 mM sodium orthovanadate, and 1 mM
dithiothreitol as reported previously (2).
Immunoprecipitations were performed using 0.5 mg of total lysate in HNTG
buffer (20 mM HEPES, 150 mM NaCl, 10% glycerol, 0.1% Triton X-100) plus
the specific agarose-conjugated primary antibody, with gentle rocking overnight
at 4°C. When primary antibodies were not agarose conjugated, protein A or
protein G Sepharose 4 Fast Flow (Amersham Biosciences) was added during the
last 2 h of incubation. Immunoprecipitates were washed six times in HNTG
buffer, and then nine parts were resuspended in 3 Laemmli sample buffer with
50 mM dithiothreitol and one part was resuspended in kinase buffer. Kinase
assays were performed as previously described (2, 37) using 2 g of histone H1
as the substrate (Upstate Biotechnology) and [-32P]ATP to reveal phosphory-
lation levels.
For immunoblotting, 40 g of proteins was separated by 4 to 20% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (Criterion precast gel; Bio-
Rad) and transferred to nitrocellulose membranes (Hybond C; Amersham Inc.).
Membranes were incubated with primary antibodies as indicated and then with
horseradish peroxidase-conjugated secondary antibodies (GE Healthcare) for
ECL detection (GE Healthcare) or Alexa-conjugated secondary antibodies (In-
vitrogen) for Odyssey infrared detection (Licor). For immunoprecipitates, rabbit
immunoglobulin G and mouse immunoglobulin G True Blot (eBioscience) sec-
ondary horseradish peroxidase-conjugated antibodies were used, following the
manufacturer’s instructions.
Primary antibodies were from Transduction Laboratories (p27, cyclin-depen-
dent kinase 1 [CDK1], CDK2, and cofilin), Cell Signaling (phosphorylated serine
3 [pS3]-cofilin), Santa Cruz (sc-54 CDK1, sc-245 cyclin B1, sc-751 cyclin A,
sc-7649 vinculin, and sc-19 c-Src,), and Sigma (OP18/stathmin and -tubulin).
Growth curve, MTT assay, FACS analysis, and anchorage-independent cell
growth. Cell proliferation was evaluated using growth curves, 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, fluorescence-acti-
vated cell sorting (FACS) analysis after propidium iodide incorporation, and
soft-agar assay, as previously described (1). For the MTT assay (Sigma), 1,000
cells/well were seeded in 96-well plates. At the indicated times, MTT solution in
complete medium (0.28-mg/ml final concentration) was added and incubated at
37°C for 4 h. The medium was discarded, and the formazan salts were dissolved
in dimethyl sulfoxide. The colorimetric substrate was measured and quantified at
560 nm in an enzyme-linked immunosorbent assay plate reader.
For cell growth, 1  105 cells/well were seeded in six-well plates in complete
medium. At the indicated times, cells were detached in trypsin-EDTA, resus-
pended in trypan blue, and counted.
The cell cycle profile was analyzed by propidium iodide staining (50 g/ml
propidium iodide and 100 g/ml RNase A) followed by FACS analysis, as
described elsewhere (1, 2). The data were analyzed using WinMDI2.8 software.
To analyze the anchorage-independent cell growth, cells (1 103 and 5 103)
were suspended in 2 ml top agar medium (DMEM-10% FBS, 0.4% low-melting-
point agarose) and kept at 42°C until needed. The cell suspension was then
quickly overlaid on 2 ml of previously layered bottom agar medium (DMEM-
10% FBS, 0.6% low-melting-point agarose) in six-well tissue culture plates in
triplicate. DMEM-10% FBS with 1.5 g/ml puromycin and/or 0.4 mg/ml hygro-
mycin was added to the wells every 3 days as a feeder layer. On day 8, the number
of colonies was counted in 15 random fields at a magnification of 10.
Immunofluorescence of cells included in 3D matrices. Single cells included in
3D Matrigel or collagen I were fixed in phosphate-buffered saline (PBS)–4%
paraformaldehyde for 20 min at room temperature and then permeabilized in
PBS with 0.2% Triton X-100 and blocked for at least 2 hours in PBS with 1%
bovine serum albumin and 10% normal goat serum (Dako). Incubation with
fluorescein isothiocyanate (FITC)-conjugated monoclonal anti--tubulin anti-
body (Sigma) and phallotoxin-AlexaFluor546 (Molecular Probes, Invitrogen) for
actin staining was performed for 2 hours at room temperature in PBS–1% bovine
serum albumin and 1% normal goat serum. Incubation with anti-pSer3-cofilin
(Cell Signaling) and anti-acetylated tubulin (Sigma) was performed overnight at
4°C, followed by anti-rabbit–AlexaFluor488 and anti-mouse–AlexaFluor488
staining, respectively. 1-Integrin expression was revealed using an anti-1-
integrin FITC-conjugated antibody (BD) by incubating the cells overnight at 4°C.
For imaging of collagen fibers, laser light at a low density (the “reflection”
parameter in confocal microscopy) was used. Immunofluorescence-labeled cells
were studied using a confocal laser-scanning microscope (Diaphot 200 Nikon;
MRC-1024, Bio-Rad Laboratories) or a Leica epifluorescence microscope.
Quantification of pS3-cofilin, acetylated tubulin, and phalloidin fluorescence
intensities was performed using the Leica LAS software and analyzing at least 40
cells/clone.
Evasion assays. For evasion assays, cells (7.5  105cells/ml) were included in
Matrigel (BD) (6-mg/ml final concentration) or collagen type I (BD or Purecol-
Nutacon) (1.7-mg/ml final concentration) drops (10 l of matrix volume per
drop). The drops, sufficiently spaced, were dispensed on the bottom of cell
culture dishes and maintained for 1 h upside down to polymerize at 37°C.
Matrigel was diluted in complete medium, whereas collagen I was diluted in a
solution containing 10 DMEM (without phenol red), 7.5% sodium bicarbon-
ate, and complete medium. After polymerization, the plates were turned on and
the drops were incubated for the indicated times in complete medium.
Cell motility was assessed by transmission microscopy using a Nikon TS100/F
microscope. Images were collected using a digital camera (Nikon Coolpix 995).
Cells present outside each drop (five drops per cell line per experiment) were
counted to estimate their evasion ability using a 10 objective.
Animal experiments. Primary tumors were established by subcutaneous injec-
tion of 1  106 transformed cells into the flanks of female athymic nude mice
(Harlan, 8 weeks of age). At 15 days after injection, the animals were sacrificed
and tumor analysis was performed. Spleen samples were also collected and
rapidly frozen for RNA extraction.
A second experiment was performed with 1  106 cells injected into the tail
veins. After 1 month or 20 days, as indicated, the animals were sacrificed and
lung analysis was performed.
Tissue samples, RNA extraction, and reverse transcription-PCR (RT-PCR).
Isolation of total RNA from spleen samples was performed using the RNeasy
minikit (Qiagen). After retrotranscription with avian myeloblastosis virus reverse
transcriptase and random primers according to the provider’s instruction
(Promega), the obtained cDNAs were amplified by nested PCR in order to
evaluate the presence of the injected cells in spleen samples. The following
primers designed on vectors were used: pTREforward1, 5-CAGCAGGCAG
AAGTATGCAA-3; pTREforward2, 5-TGCAAAGCATGCATCTCAAT-
3; pTREreverse1, 5-CGTGAGGAAGAGTTCTTGCAG-3; pTREreverse2,
5-AGTTCTTGCAGCTCGGTGAC-3; pMSCVforward, 5-CCCTTGAACC
TCCTCGTTCGACC-3; pMSCVreverse, 5-GAGACGTGCTACTTCCATT
TGTC-3; and p27-170reverse 5-GGATCCCTCGAGTGTTCTGTTGGCTC
TTTT-3.
Statistics. Statistical analysis was done using the two-tailed unpaired Student
t test or the two-tailed unpaired Mann-Whitney U test. Differences were con-
sidered significant at a P value of 0.05.
RESULTS
p27/ transformed cells exhibit higher proliferation poten-
tial than p27/ cells. To gain new information on the role of
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p27 during the process of cell transformation, the oncogene
v-src was used to transform mouse fibroblasts derived from
p27/ and p27/ embryos. Independent cell clones stably
overexpressing comparable levels of v-src for each genotype
were fully characterized (Fig. 1A). In agreement with the lit-
erature data (22, 39), we observed a decrease in the amount of
endogenous p27 after v-src transformation, and the relative
lower p27 levels remained constant and were confirmed after
each experiment (Fig. 1A and data not shown).
Since p27 is a well-known tumor suppressor gene able to
inhibit cell proliferation, the selected clones were initially an-
alyzed for their proliferative behavior. FACS analysis of the
DNA content in exponentially growing cells demonstrated that
p27/ v-src-transformed fibroblasts (referred to below as v-src
fibroblasts) displayed a higher S-phase population than WT
cells (Fig. 1B). Accordingly, both cell growth curves and MTT
proliferation assays (Fig. 1C), demonstrated that the v-src-
mediated cell proliferation rate could be further increased
when p27 expression was fully abrogated.
It is well accepted that p27 regulates cell cycle progression
by interacting with and inhibiting different cyclin-CDK com-
plexes, in particular by impairing the activity of CDK2- and
CDK1-containing complexes (reviewed in reference 2a).
Hence, the activity of CDK2, and to a lesser extent that of
CDK1, was higher in p27KO than in p27WT v-src cells (CDK2,
P	 0.002; CDK1, P	 0.07 [for WT versus KO using Student’s
t test]), although some clonal variability was detected (Fig.
1D). Similar results were obtained by assaying the cyclin A-
and B1-associated kinase activities (Fig. 1D) (cyclin A, P 	
0.01; cyclin B1, P 	 0.05 [for WT versus KO using Student’s t
test]), thus providing a molecular explanation for the different
proliferation rates observed.
To specifically analyze the contribution of p27 in the G1-S
transition in v-src-transformed cells, we synchronized the cells
in the G1 phase by serum starvation and then stimulated them
to reenter the cell cycle by release in complete medium. Cells
normally progressing through the cell cycle, such as p27/
and p27/ 3T3 fibroblasts, were used as a control. While
normal cells arrest in G1 phase after serum starvation and
enter the S phase about 15 h after serum stimulation (see Fig.
S1A and S1B in the supplemental material), v-src-transformed
fibroblasts were less sensitive to growth factor deprivation, as
demonstrated by both FACS analysis of DNA content (see Fig.
S1C in the supplemental material) and Western blot analysis of
typical markers of the S (cyclin A) or G2-M (cyclin B1) phases
of cell cycle (see Fig. S1D in the supplemental material). Im-
portantly, FACS analysis of transformed cells grown to conflu-
ence demonstrated that p27 expression is necessary to induce
FIG. 1. The absence of p27 in v-src-transformed cells provides a proliferative advantage in vitro. (A) Western blot analysis of v-src and p27
expression in p27/ and p27/ v-src-clones. -Tubulin was used to normalize the amount of loaded proteins. (B) Cell cycle distribution of
exponentially growing p27/ and p27/ v-src cells evaluated by FACS analysis. The percentage of cells in each phase of the cell cycle is reported
in the graph and represents the mean (
 standard deviation) from three independent experiments. (C) Growth curve analysis (upper graph) and
MTT assay (lower graph) of p27/ and p27/ v-src cells. Data represent the means and standard deviations from three independent experiments
performed in triplicate (growth curve) or six times (MTT assay) (P	 0.001 for growth curve and P	 0.0001 for MTT assay at day 4 using Student’s
t test). (D) Kinase activity associated with CDK2, CDK1, cyclin A, and cyclin B1, using histone H1 as the substrate. In the lower panels the amount
of immunoprecipitated (IP) protein is shown. The normalized kinase activities (expressed in arbitrary units) reported under each lane represent
the means (
 standard deviations) from three independent experiments.
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G1 arrest after cell-cell contact, whereas it is dispensable in
normal cells (see Fig. S1E and S1F in the supplemental mate-
rial), as previously reported (32). Overall these data demon-
strated that p27 plays an important role in the control of cell
cycle progression also in v-src-transformed cells and that, as
expected, its major function is carried out during the G1-S
transition.
The tumorigenic potential of v-src fibroblasts was then tested
in vitro by soft-agar assay. Both p27/ and p27/ v-src fi-
broblasts were able to grow in an anchorage-independent way
in soft agar, although p27-null cells displayed a significant
growth advantage both in the number and in the size of the
colonies formed (Fig. 2A and B).
Next, two different clones of p27/ and p27/ v-src fibro-
blasts were subcutaneously injected in nude mice (n 	 21 for
p27/ cells and n 	 20 for p27/ v-src cells). Xenografts
were monitored for 15 days, and then the mice were sacrificed
and the tumor masses analyzed. The data showed that tumors
formed from p27/ transformed cells were significantly larger
than those from the WT counterpart (Fig. 2C and D). Immu-
nohistochemical analysis confirmed that tumors formed by
p27/ v-src cells express p27 protein both in the nucleus and
in the cytoplasm (Fig. 2E). Further, the pathological analysis
demonstrated that tumors formed by p27-null cells displayed
an increased number of mitotic figures (Fig. 2F and G) that
were often classified as atypical mitosis (Fig. 2F, inset), indi-
cating that p27/ v-src cells formed hyperproliferative and
less differentiated tumors. No significant variations were ob-
served between the two WT and the two KO cell clones utilized
(Fig. 2C and D), thus excluding bias due to clonal selection.
p27 expression discriminates between mesenchymal and
amoeboid morphology and motility. Recently, the role of p27
in cell motility has become a debated issue in the scientific
literature. We previously demonstrated a reduction in ECM-
driven cell migration when p27 is expressed at the cytoplasmic
level (1). We thus tested whether p27 could be involved in the
regulation of cell morphology and motility during oncogenic
transformation. p27/ and p27/ v-src fibroblasts were in-
cluded in a 3D collagen I matrix, and their morphology was
first evaluated at different time points by bright-field transmis-
sion microscopy to better discriminate the cell distribution
along the z axis (Fig. 3A, upper panels). v-src-transformed
fibroblasts included in 3D matrices typically acquired two
different shapes: an elongated spindled shape with finger-
like protrusion at the cellular edges or a rounded morphol-
ogy characterized by numerous peripheral membrane ruf-
fles. Counting the rounded versus the elongated cells, we
could verify that while p27/ fibroblasts displayed similar
percentages of elongated and rounded cells (47.8% 
 7%
elongated cells), p27/ v-src fibroblasts acquired almost ex-
clusively the rounded morphology (86%
 3.3% rounded cells)
(Fig. 3B). We next evaluated the organization of the cytoskel-
etal components of transformed cells in 3D using immunoflu-
orescence and confocal microscopy analysis. p27/ and
p27/ v-src fibroblasts were cultured for 10 h within the col-
lagen I matrix and then fixed and stained for -tubulin and
F-actin (Fig. 3A, bottom panels). This analysis confirmed that
transformed p27/ cells retained a fibroblast-like elongated
morphology with cellular protrusions that were positive for
both microtubules (MTs) and the actin cytoskeleton. Con-
versely, p27/ v-src cells mainly displayed a rounded shape,
lost the dendritic-like extensions, and showed a cortical distri-
bution of actin and a perinuclear distribution of MTs (Fig. 3A).
The same morphological differences also emerged in time-
lapse video microscopy of multicellular spheroids included in
the 3D collagen matrix. As shown by the photograms collected
after 0 and 6 h (Fig. 3C) and by the movies obtained by
collecting one picture every 4 min (see Videos S1 and S2 in the
supplemental material), when p27/ v-src cells detached from
the cell cluster, they retained a rounded morphology and
showed a higher deformability. They were able to squeeze the
cellular body through the collagen fibrils, moving in a propul-
sive way with a reduced directional persistence. Conversely,
p27/ transformed fibroblasts moved from the cluster using
long protrusions aimed to generate the traction force needed
for the cell body to advance (Fig. 3C; see Videos S1 and S2 in
the supplemental material). The features that emerged from
these experiments were highly suggestive of the described
model for the amoeboid and the mesenchymal types of mor-
phology and motility (16). Because the amoeboid mechanism is
defined as an extracellular protease-independent and Rho-
dependent invasion while mesenchymal invasion is metallopro-
teinase and integrin dependent and Rho independent (41, 50),
we looked at the expression of 1-integrin and investigated the
role of metalloproteinases and Rho activity in the motility of
p27/ and p27/ v-src cells. In p27/ spindle-shaped cells
immersed in 3D collagen, 1-integrin forms clusters that are
absent in p27/ round cells, which show a nonclustered, lin-
ear surface distribution of 1-integrin (see Fig. S2A in the
supplemental material), compatible with the differences be-
tween mesenchymal and amoeboid cells in the different model
systems (50).
To test the dependence of p27/ and p27/ v-src cells on
the activity of metalloproteinases, we blocked their activity
using the chemical inhibitor GM-6001. Under these condi-
tions, WT cells tended to assume a round morphology both in
spheroid assays and in single-cell assays (Fig. 3C and data not
shown; see Video S3 in the supplemental material). Con-
versely, in the absence of p27, GM-6001 did not alter the
amoeboid motility of src-transformed cells (Fig. 3C and data
not shown; see Video S4 in the supplemental material). We
then tested the involvement of the Rho pathway in the motility
of both cell lines using the ROCK inhibitor Y27632. This
compound did not modify the shape or motility mode of WT
cells (Fig. 2C and data not shown; see Video S5 in the supple-
mental material), while a striking conversion from amoeboid to
mesenchymal motility was observed in p27-null cells both in
spheroid assays and in single-cell assays (Fig. 3C and data not
shown; see Video S6 in the supplemental material).
Overall, these data imply that p27 acts as a novel regulator
of the cellular shape and motility during the v-src transforma-
tion process, since its absence favors the acquisition of an
amoeboid motility.
The amoeboid motility of p27/ v-src cells is associated
with higher cell speed and invasive ability. To evaluate
whether the two morphologies and migration modes observed
in p27/ and p27/ v-src fibroblasts resulted in a difference
in the migration efficiency, we performed time-lapse video
microscopy coupled with cell tracking analysis of individual
cells included in the 3D collagen matrix (Fig. 4A and B; see
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Videos S7 and S8 in the supplemental material). This analysis
demonstrated that p27/ v-src cells had a twofold-higher cell
speed than the WT counterpart (speeds of 0.227 and 0.118
m/min for WT and KO cells, respectively). (Fig. 4A). The
difference in speed is statistically highly significant, and it is
also well represented by the observation of the cell trajectories,
showing how p27/ transformed cells definitely cover longer
paths than WT cells in the same time frame (Fig. 4B). Similar
results emerged from other migration assays, such as cell eva-
sion from drops of either collagen I or Matrigel matrices. In
FIG. 2. Absence of p27 in v-src-transformed cells provides a growth advantage in vivo. (A and B) Soft-agar assay of v-src-transformed cells. In
panel A, representative pictures of colonies after 8 days of incubation in agar are shown. Bar, 50 m. In panel B, the quantification representing
the means and standard deviations from three independent experiments each performed in triplicate is reported. For each cell line at least 15
randomly selected fields (10 objective) were counted (P  0.001 for p27/ versus p27/ by Student’s t test). (C) Typical images of tumors in
nude mice injected with 1 106 p27/ (left) and p27/ (right) v-src cells. (D) A representative picture of tumors explanted 15 days after injection
and quantification of tumor mass, representing the mean values and standard deviations for 11 mice for p27/ v-src A4, 10 mice for p27/ v-src
A6, and 10 mice for p27/ v-src 3 and 11. (E) Representative image of p27 expression in tumors formed by p27/ v-src cells. A nucleocytoplasmic
expression of p27 is clearly visible in the inset at higher magnification. (F) Representative images of hematoxylin-eosin staining performed on
explanted xenografts, as indicated. Black arrows indicate normal mitoses. Red arrows indicate atypical mitoses. The insets show higher magnifi-
cation of a normal mitosis in p27/ v-src tumors (upper panel) and of an atypical mitosis in p27/ v-src tumors (lower panel). (G) Quantification
of mitotic figures obtained by analyzing 10 consecutive high-power fields in five tumors for each genotype. Error bars indicate standard deviations.
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agreement with the tracking data, p27/ v-src cells displayed
a greater ability than p27/ cells to exit from drops, confirm-
ing that p27-null cells have a higher capacity to move in 3D
(Fig. 4C). Interestingly, in a 2D wound-healing assay, p27/
v-src cells did not display any motility advantage with respect to
p27/ v-src cells (see Fig. S2B in the supplemental material),
supporting the hypothesis that molecular requirements for 2D
migration and 3D migration are distinct.
In order to determine if the motile behavior observed in
vitro could be linked to different metastatic potentials in vivo,
we evaluated the abilities of p27/ and p27/ v-src cells to
both intravasate and extravasate. To evaluate the intravasa-
tion, mice were injected subcutaneously with p27/ and
p27/ v-src cells (n 	 9 per genotype) and analyzed, 2 weeks
later, for the presence of transformed cells in the spleen by
RT-PCR with primers designed on the transfected vector (Fig.
5A and B). While none of the mice injected with p27/ v-src
cells (0/9) was positive for the presence of transformed cells in
the spleen, 4/9 mice injected with p27-null cells were positive.
The ability to extravasate, settle, and colonize distant sites
was also evaluated. In an experiment aimed to evaluate the
survival of mice following metastasis formation, we injected
transformed fibroblasts into the tail veins of nude mice (n 	 4
per genotype). The mice were sacrificed when they displayed
breathing defects and fatigue (1 month later), and by simple
macroscopic observation of the lungs, a massive difference was
already observed, with more than a 10-fold difference in the
number of tumor foci per lung (Fig. 5C).
All the in vitro and in vivo results suggested that the absence
of p27 in v-src-transformed fibroblasts induces an increased
proliferation coupled with a motility advantage that could be
attributed to the switch from a mesenchymal to an amoeboid
motility mode.
p27 expression in p27/ v-src cells reduces proliferation
and tumor growth. To validate that the observed effects on the
proliferative behavior were due to p27 itself, we stably reintro-
duced p27 in p27/ v-src cells. To avoid or reduce the v-src-
induced degradation of p27 WT protein, we used the cDNA
coding for two less degradable forms, p27T187A and p271–170
(Fig. 6A). p27T187A carries a point mutation that impairs p27
degradation via the ubiquitin-dependent proteasome pathway
(31, 46). The deletion mutant p271–170 also lacks this residue,
and we previously demonstrated that it retains the ability to
block cell proliferation while losing the migration-inhibitory
properties of the WT protein (1). We selected several inde-
pendent p27-rescued clones and pools expressing comparable
levels of v-src and p27 proteins (Fig. 6A).
In v-src-transformed fibroblasts, both p27 mutants were able
to reduce cell proliferation to the levels observed in the p27/
v-src cells, as shown by growth curves and MTT proliferation
assays (Fig. 6C and data not shown). Western blot analysis of
cell cycle-regulating proteins demonstrated that all of the an-
FIG. 3. p27/ v-src cells assume a rounded morphology and preferentially use amoeboid-like motility in a 3D environment. (A) Representative
pictures of p27/ and p27/ transformed fibroblasts after 10 h of inclusion in 3D collagen I. In the upper panels, typical bright-field images
acquired using a 10 objective are shown. In the lower panels, confocal images of the cells stained for F-actin with phalloidin-AlexaFluor546
(pseudocolored in red) and for MTs with antitubulin-FITC (pseudocolored in green) are shown. In gray, the collagen fibers acquired using the
reflection parameter are represented. Bar, 24 m. (B) Quantification of the cellular shape assumed by p27/ and p27/ transformed fibroblasts
included in 3D collagen I. Cells were classified as rounded or elongated. The results represent the means and standard deviations from three
independent experiments in which five randomly selected fields were counted. (C) Cell spheroids were included in a 3D collagen matrix and treated
with the metalloproteinase inhibitor GM6001 (10 M) or with the ROCK inhibitor Y27632 (10 M). Complete medium was used as a control.
Spheroids were evaluated by bright-field microscopy, collecting one picture every 4 min for at least 12 h. The photograms collected after 0 and 6 h
of incubation at 37°C in a typical experiment are reported. Bar, 50 m.
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alyzed cell clones expressed similar amounts of cyclin A, cyclin
B1, CDK1, and CDK2 (Fig. 6B). However, kinase assays dem-
onstrated that reintroduction of both p27T187A and p271–170 in
p27/ v-src cells strongly reduced the CDK activity associated
with CDK2, cyclin A, cyclin B1, and, to a lesser extent, CDK1
(Fig. 6D). Interestingly, as in the comparison between WT and
KO cells, also in the case of KO cells reexpressing p27T187A and
p271–170, the higher inhibitory activity was observed for CDK2-
containing complexes (CDK2, P	 0.001; CDK1, P	 0.06; cyclin
A, P	 0.006; cyclin B1, P	 0.009 [for p27T187A versus KO using
Student’s t test]; CDK2, P 	 0.0005; CDK1, P 	 0.06; cyclin A,
P  0.0001; cyclin B1, P 	 0.006 [for p271–170 versus KO using
FIG. 4. p27/ v-src cells included in 3D matrices display increased motility. (A) Single-cell speed of p27/ and p27/ v-src fibroblasts
included in 3D collagen I, calculated using time-lapse video microscopy coupled with semiautomatic cell tracking. Data represent the means from
three independent experiments in which 40 cells for each cell line were tracked (P  0,0001; Mann-Whitney U test). In the box plots the median
value (line within the box), the interquartile range representing 50% of the data (boundaries of the box), and the spread (vertical lines)
representing the highest and lowest value (horizontal lines) are shown. (B) Orthotopically projected cell paths of p27/ and p27/ v-src
fibroblasts in 3D collagen I. The mean (
 standard deviation) path length from three independent experiments is reported (P 1012 by Student’s
t test). (C) Evasion assay of p27/ and p27/ v-src-transformed fibroblasts in collagen I or Matrigel drops (as indicated). Pictures show cells that
exited from the matrix drops 24 h after the inclusion. The dashed line indicates the drop edge.
FIG. 5. p27/ v-src cells display increased intravasation and extravasation abilities in vivo. (A and B) RT-PCR on RNA extracts from mouse spleens,
using specific primers to identify transformed cells. Mice were injected subcutaneously with v-src cell clones (n 	 9 for genotype) and analyzed for the
presence of tumor cells in the spleen. The ribosomal 18S subunit was used as a control for RNA integrity and amount. The cDNA derived from one
primary tumor was used as positive control (). B and B1 indicate the negative control and the blank. (B) Numbers of positive and negative spleens.
(C) Representative picture of lungs explanted from mice injected in the tail veins with v-src-transformed fibroblasts 1 month after the injection. The means
(
 standard deviations) of the number of macroscopic lesions per lung in four animals per genotype are also reported.
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FIG. 6. Reexpression of p27 in p27/ v-src cells reduces their in vitro and in vivo growth. (A) Western blot analysis of v-src and p27 expression
in the indicated cell clones. Vinculin was used to normalize the amount of proteins present in each lane. (B) Western blot analysis of cyclin A, cyclin
B1, CDK1, CDK2, and vinculin expression in exponentially growing cells. (C) Growth curve analysis of p27/ v-src p27T187A (upper graph) and
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Student’s t test]). No significant differences in the kinase activities
associated with CDK1 and CDK2 were noted between KO cells
expressing p27T187A or p271–170.
Moreover, both p27T187A and p271–170 were able to reduce
the tumorigenic potential of p27/ v-src cells in vitro and in
vivo, as demonstrated by soft-agar assay (Fig. 6E and F) and in
vivo analysis of tumor growth in nude mice after subcutaneous
injection (Fig. 6G) (n 	 6 for p27/ and p27/ v-src cells,
n 	 8 for the p27T187A pool, and n 	 9 for p271–170 clones).
p27T187A but not p271–170 rescues the morphology and mo-
tility phenotypes of p27/ v-src cells. We next analyzed the
3D cell shape and motile behavior of p27-rescued cells in order
to determine whether p27T187A and p271–170 could differently
affect these phenotypes. First, cells included in 3D collagen I
matrices were analyzed for their morphology after 10 h. As
described above for p27/ and p27/ v-src cells, p27-rescued
cells also acquired two different morphologies in 3D, namely,
the elongated and the rounded morphologies (Fig. 7A and B).
Interestingly, many p27T187A v-src cells clearly appeared to
have the elongated and bipolar shape (49.6% 
 16% of elon-
gated cells), similarly to p27/ v-src cells (47.8% of elongated
cells). In contrast, almost all p271–170 cells (96% 
 2.9%) were
rounded, as described for p27/ v-src cells (86% 
 3.3%
rounded) (Fig. 7A and B). The morphological differences were
evaluated by confocal microscopy analysis after staining of
-tubulin (green) and actin (red). p27T187A v-src cells appeared
to have an elongated spindle shape based on both MTs and
actin stress fiber content, while p271–170 expression was not
able to rescue the morphological phenotype in p27-null v-src
fibroblasts and these cells still displayed a typical rounded
amoeboid-like shape with cortical actin distribution and pe-
rinuclear MT accumulation (Fig. 7C).
Interestingly, the behavior of cell clusters in 3D collagen I
also supports the data obtained by analysis of individual cells
(Fig. 7D; see Videos S9 and S10 in the supplemental material).
In brief, p27T187A reverted the phenotype of p27/ v-src fi-
broblasts, and cells displayed long cellular protrusions (Fig.
7D; see Video S9 in the supplemental material) that allowed
detachment from the spheroid using typical mesenchymal
mechanisms. Conversely, p271–170-expressing cells detached
from the spheroid using an amoeboid-like motility, showing a
markedly spherical shape (Fig. 7D; see Video S10 in the sup-
plemental material), highly dynamic membrane blebs, and
squeezing through the collagen lattices in a very flexible way,
thus reproducing the motility behavior of p27-null cells. This
different motility was coupled with a very high ability of p271–170
cells to evade 3D matrices, as demonstrated by evasion assays
of individual cells included in collagen I and Matrigel drops
(Fig. 8A and B). At 24 h after inclusion, only a few p27/ v-src
and p27T187A-rescued cells exited the matrix drop. Conversely,
p271–170 expression was not able to reduce cell migration of
p27-null v-src fibroblasts, and many cells were present outside
the drops in the same time frame (Fig. 8A). The count of all
cells that evaded the matrix (five drops for each cell line)
confirmed this observation, using both collagen I and Matrigel
matrices (Fig. 8B).
Decreased MT stability in p27/ v-src fibroblasts influ-
ences their biological behaviors. We previously demonstrated
that the C-terminal portion of p27 is necessary to mediate the
stabilization of the microtubular network via the inhibition of
the MT-destabilizing protein stathmin (1). The fact that rein-
troduction of the p271–170 deletion mutant in p27/ v-src
fibroblasts was not able to rescue the biological phenotype of
transformed cells suggested that the same mechanism could
also operate in this context. To verify whether the v-src-trans-
formed p27/ cells immersed in 3D environments displayed
altered MT stability, we looked at the levels of stable acety-
lated tubulin in cells included in 3D collagen I. This analysis
clearly showed that cells expressing endogenous p27 or
p27T187A displayed higher levels of acetylated tubulin, local-
ized both in the cell body and in the cellular protrusions (Fig.
8C). Conversely, p27-null and p271–170-expressing cells dis-
played very low levels of acetylated tubulin, and, to a larger
extent, localized perinuclearly. Moreover, in the latter cells,
intact MTs were hardly distinguishable, while they could be
easily identified in cells expressing full-length p27 proteins
(Fig. 8C). The quantification of the fluorescence intensities of
phalloidin and acetylated tubulin in the different cell lines
included in 3D collagen revealed that p27WT and p27T187A
cells had a threefold-higher content of stable acetylated MTs
with respect to both p27KO and p271–170 cells (Fig. 8D). This
result was consistent with previous reports showing a lower MT
stability in cells devoid of p27 (1). We thus tested whether MT
stability could influence the cell shape and motility of these
cells, using the MT-stabilizing drug taxol. p27/ v-src cells
were treated with low doses of taxol (10 nM) and analyzed for
their proliferative, morphological, and motility profiles. Prolif-
eration was not affected by 10 nM taxol (Fig. 8E), but cells
immersed in 3D collagen I significantly changed their shape, by
assuming an elongated morphology coupled with mesenchymal
motility, as demonstrated by the 3D spheroid assay (Fig. 8F;
see Video S11 in the supplemental material). Importantly, the
ability of p27-null cells to move in the presence of taxol was
greatly reduced, starting to detach from the spheroid only after
p271–170 (lower graph) v-src fibroblasts. Data represent the means and standard deviations from three independent experiments performed in
duplicate, in which the cells were counted each day for 5 days (P 	 0.001 for p27/ v-src versus p27T187A and p271–170 at day 5 using Student’s t test).
(D) Cyclin A-, cyclin B1-, CDK1-, and CDK2-associated kinase activity, using histone H1 (32P-HH1) as a substrate (upper panels). In the lower
panels the amount of immunoprecipitated (IP) protein is shown. The normalized kinase activities (expressed in arbitrary units) reported under
each lane represent the means (
 standard deviations) from three independent experiments. (E and F) Soft-agar assay of the indicated
v-src-transformed cells. In panel E, representative pictures of colonies after 8 days of incubation in agar are shown. In panel F, the number of
colonies per field is reported, representing the means and standard deviations from three independent experiments each performed in triplicate
(*, P 	 0.007; §, P  0.0001 [versus p27
/ v-src cells, using Student’s t test]). (G) Quantification of tumor masses explanted from mice
subcutaneously injected with the indicated cells. Values represent the means and standard deviations for six mice injected with p27/ v-src cells,
six mice injected with p27/ v-src cells, eight mice injected with p27T187A v-src cells, and nine mice injected with p271–170 v-src cells (*, P  10
5
versus p27/ v-src cells, using Student’s t test).
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3 h of incubation (Fig. 8F; see Video S11 in the supplemental
material). Altogether, these results strongly support the hy-
pothesis that the lower MT stability observed in p27/ v-src
cells represents an important variable in the acquisition of
their biological phenotype.
Next we asked how this altered stability of MTs observed in
p27-null cells could result in an altered cell shape. Our exper-
imental observations using the ROCK inhibitor Y27632 (Fig.
3C; see Videos S5 and S6 in the supplemental material), cou-
pled with literature data, suggested that the absence of p27
could affect RhoA activity, and this in turn favors amoeboid
motility, as demonstrated in 3D settings (40, 41). We thus
investigated whether p27-null v-src cells display different levels
of RhoA activity in 3D, using as the readout the levels of
pS3-cofilin, an accepted marker of RhoA activation (40, 41). In
agreement with their morphological and motility phenotypes,
FIG. 7. Only p27T187A reverts the rounded morphology of p27/ v-src cells. (A) Representative pictures of the morphology acquired by
p27T187A, p271–170, p27/, and p27/ v-src-transformed fibroblasts after 10 h of inclusion in 3D collagen I. Pictures were collected by bright-field
microscopy using a 10 objective. (B) Quantification of the cellular shape assumed by the indicated fibroblasts included in 3D collagen I. Cells
were classified as rounded or elongated. The results represent the means (
 standard deviations) from three independent experiments in which
five randomly selected fields were counted. (C) Confocal images of p27/, p27/, p27T187A, and p271–170 v-src cells included for 10 h in 3D
collagen I and then stained with phalloidin-AlexaFluor546 (pseudocolored in red) and antitubulin-FITC (pseudocolored in green). Bar, 24 m.
(D) Spheroids of the indicated cell lines were included in a 3D collagen matrix and observed by bright-field microscopy by collecting one picture
every 5 min for at least 12 h. Photograms collected with a 20 objective after 0, 3, 6, and 9 h are reported. Bar, 50 m.
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p27-null cells included in 3D had higher levels of pS3-cofilin
(Fig. 9A and B), which also resulted in high polarization in
migrating cells detached from the spheroid, as evaluated by
immunofluorescence analysis (data not shown). The higher
adhesion-dependent pS3-cofilin phosphorylation was con-
firmed by Western blot analysis of cells adhered to collagen I
for 30 and 60 min (Fig. 9C and D), and, importantly, this is
dependent on the presence of the last 28 C-terminal amino
acids in p27 (Fig. 9), in accord with the fact that p271-170 cells
retain the round shape and the amoeboid motility of p27-null
cells.
The invasive potential of p27/ v-src cells is reduced by
p27T187A expression. The importance of the C-terminal por-
tion of p27 in controlling cell shape and motility in metastasis
formation was then tested in nude mice by examining the
ability of p27T187A- and p271–170-rescued cells to intravasate
from the primary site and to extravasate and form tumor foci
into the lungs when injected in the blood circulation.
RT-PCR analysis of the spleens, amplifying the exogenous
cDNAs, showed that only 1/7 mice (14.2%) injected subcuta-
neously with p27T187A-rescued cells displayed a positive spleen,
whereas 3/5 mice (60%) injected with p271–170-rescued cells
were positive (Fig. 10A). Moreover, tail vein injection of four
mice with p27/ and p27/ v-src cells as controls, seven mice
with two different p27T187A-rescued cell lines, and six mice with
two different p271–170-rescued clones revealed that p27/ v-
src cells showed a higher ability to settle and form tumor foci
in the lungs (10.5 foci per mouse), while p27/ cells were
much less aggressive (no macroscopically evident foci) (Fig.
10B). Interestingly, mice injected with p27T187A-rescued cells
displayed on average 1.95 foci per animal, while the p271–170
counterpart showed 6.41 foci (Fig. 10B). Histopathological
analysis of lungs from the different mice confirmed the results,
demonstrating an increased number of tumor foci per section
in mice injected with p271–170 v-src cells with respect to
p27T187A-expressing cells (tumor foci per lung section: p27/
v-src, 0; p27/ v-src, 6; p27T187A, 2.1; p271–170, 4.3). More
importantly, the immunohistochemical analysis of p27 expres-
sion in lung foci formed by p27T187A and p271–170 v-src cells
demonstrated that p27 expression was significantly retained
only in those foci formed by the p271–170 v-src cells (Fig. 10C),
further confirming the antimetastatic role of full-length p27 in
this model system.
DISCUSSION
Here we demonstrate that p27 protein plays an important
role in the control of tumor cell growth and metastasis forma-
tion. This protein, first identified as a universal CDK inhibitor
and tumor suppressor gene product (12, 44), has in more
recent years been found to have several unexpected functions
that are often not directly linked to its ability to block the
cyclin-CDK complexes, such as the control of apoptotic cell
death (25, 26) or autophagy (24, 25), DNA transcription (30,
33), and cell motility (1, 4, 11, 19, 21, 23, 29, 45). These
different p27 functions have often been linked to different
protein domains and/or posttranslational modifications. Here,
we add a new function for p27 in the control of cell plasticity
in 3D models that eventually results in the control of cell
motility. Its C-terminal portion governs this new p27 function,
which is very well highlighted in 3D while less observable in 2D
settings. Similar observations were obtained using primary
mouse embryo fibroblasts or 3T3 fibroblasts of different geno-
types (B. Belletti et al., submitted for publication), human
glioblastomas, and endothelial cells (42), demonstrating that
the mechanism used by p27 to control cell motility is general
and is not dependent on v-src transformation.
The use of time-lapse video microscopy allowed us to
demonstrate that the absence of p27 induces MAT in cells
immersed in 3D matrices. This type of motility is accompa-
nied by a profound alteration in the distribution of actin and
MT cytoskeletons that allows the cells to assume a more
flexible architecture. Importantly, our data using inhibitors
of metalloproteinases and of the Rho pathway indicate not
only that the block of matrix degradation could induce
MAT, as observed by others (50), but also that the block of
ROCK activity may induce MAT, at least in our model.
Thus, transformed cells may switch from one motility type to
another to escape from a block in cell motility imposed
either by protease or by Rho pathway inhibition, a finding
that should be taken in great account in the design of new
antimetastatic therapies.
The observation that MT stability is a major regulator of cell
plasticity in 3D (reference 3 and this study) raises the possi-
bility that MT-stabilizing drugs such as taxol, at very low doses
that do not affect cell proliferation, may be used as new anti-
metastatic agents, at least in certain types of cancer.
The data presented here demonstrate that p27 controls cell
motility through its C-terminal portion. Both in vitro and in
vivo data support the hypothesis that the last 28 amino acids
are necessary to regulate pathways different from the cyclin/
CDK activity and are important for cell shape and motility
regulation. Accordingly, our data demonstrate that the last 28
amino acids of p27 are necessary to control Rho pathway
activity, as demonstrated by higher cofilin phosphorylation in
p27-null and p271-170 v-src cells and by the dependence of their
motility on a functional ROCK pathway (Fig. 3C and data not
shown). Interestingly, higher activity of small GTPases of the
Rho family has been previously linked to the MAT in several
different model systems (18, 35, 40).
How does the C-terminal portion of p27 contribute to reg-
ulation of Rho pathway? A direct binding of p27 and RhoA
has been observed when the two proteins are concomitantly
overexpressed in 293 cells (4), although we were not able to
highlight this direct interaction in our model system (data not
shown).
Similarly, hepatocyte growth factor-dependent hepatoma
cell scatter motility has been proposed to be regulated by p27
via the modulation of Rac but not Rho activity (29). However,
the domain necessary for p27 to regulate the scatter motility
has been mapped in a different position of the protein (amino
acids 137 to 155) (29) and thus likely represents a mechanism
different from the one we observed here, which is dependent
on the regulation of the Rho pathway and on amino acids 170
to 198.
A third possibility is that p27 regulates adhesion-dependent
Rho activity indirectly through the regulation of MT stability.
Increasing evidence underscores the existence of a tight rela-
tionship between MT dynamics and small GTPase activity,
since MT stability can regulate GTPase activity (51) and, in
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turn, small GTPases can affect adhesion-dependent MT stabi-
lization (36), at least in part acting on stathmin (47). It is thus
possible that stathmin, an MT-destabilizing protein (8) that
indeed binds the C-terminal portion of p27 (1), could contrib-
ute to the regulation of Rho activity by p27. Although this
hypothesis merits a formal experimental demonstration, it is
supported by observations presented here (Fig. 7 to 9).
It could be speculated that the control of cell proliferation
and motility by p27 could represent an energy-saving way for
the cells to more easily coordinate proliferation and movement
FIG. 8. Decreased MT stability accounts for the round shape and amoeboid motility of p27/ v-src cells. (A) Matrix evasion assay of individual
cells included in Matrigel (upper panels) or collagen I drops (lower panels). Typical images of matrix drops incubated for 24 h from inclusion at
37°C are shown. (B) Quantification of the experiment shown in panel A. The number of cells that exited from matrix drops within 24 h is reported.
p27T187A (P  0.001) but not p271–170 (P not significant using the Student t test) reduces matrix cell evasion compared to that in p27/ v-src cells.
Data represent the means and standard deviations from three independent experiments performed five times. (C) Confocal images of p27/,
p27/, p27T187A, and p271–170 v-src cells included for 5 h in 3D collagen I and stained with anti-acetylated tubulin (gray scale) (upper panels). In
the lower panels the merging of phalloidin-AlexaFluor546 (red), and anti-acetylated tubulin-AlexaFluor488 (green) is shown. Bar, 24 m.
(D) Quantification of the fluorescence intensity of acetylated tubulin normalized with phalloidin for at least 40 cells per cell clone (expressed in
arbitrary units). Error bars indicate standard deviations. (E) FACS analysis of p27/ v-src cells treated or not with 10 nM taxol for 10 h and
analyzed for their cell cycle distribution. The percentage of cells in each phase of the cell cycle in a typical experiment is reported. (F) Spheroids
of p27/ v-src cells, treated or not with 10 nM taxol as indicated, were included in a 3D collagen matrix and evaluated by bright-field microscopy
by collecting one picture every 5 min for at least 12 h. Photograms collected after 0, 3, 6, and 9 h are shown. Bar, 50 m.
FIG. 9. p27/ v-src cells have higher RhoA activity. (A) p27/ and p27/ v-src cells included in 3D collagen I were stained for pS3-cofilin
(AlexaFluor488, pseudocolored in green) and nuclei (with propidium iodide, red). In the upper panels the confocal 3D reconstruction of
pS3-cofilin staining is reported. In the middle, the merging of pS3-cofilin (AF488) and nuclei (red) in a 3D reconstruction is shown. In the lower
panels a confocal section of the same field is reported. Bar, 24 m. (B) Quantification of the fluorescence intensity of pS3-cofilin in at least 40 cells
per genotype (expressed in arbitrary units). Error bars indicate standard deviations. (C) Western blot analysis of pS3-cofilin and total cofilin
expression in p27/, p27/, p27T187A, and p271–170 v-src cells adhered to collagen I (20 g/ml) for the indicated times. (D) Quantification of
pS3-cofilin, representing the ratio between pS3-cofilin and total cofilin expression in three independent experiments (*, P 	 0.01; P 	 0.005 [at
60 min between p27/ and p27/ cells and p271–170 and p27/ cells, respectively, using the Student t test; in the other cases the differences did
not reach statistical significance). Error bars indicate standard deviations.
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both under physiological and pathological conditions, using the
same protein(s) in different subcellular localization and/or its
different protein domains. This in turn implies that that the
mechanism described here could be explored in the context of
the design of new promising antimetastatic therapies.
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